A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial
- 20 September 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Heart Failure Reviews
- Vol. 17 (3), 485-509
- https://doi.org/10.1007/s10741-011-9280-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Postdischarge Assessment After a Heart Failure HospitalizationCirculation, 2010
- Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failureEuropean Journal of Heart Failure, 2010
- Measuring Quality in Heart FailureCirculation: Cardiovascular Quality and Outcomes, 2008
- Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge SurvivalCirculation: Heart Failure, 2008
- Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart FailureJAMA, 2006
- EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of populationEuropean Heart Journal, 2006
- Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)Journal of Cardiac Failure, 2005
- Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart FailureClassification and Regression Tree AnalysisJAMA, 2005
- Predicting Mortality Among Patients Hospitalized for Heart FailureJAMA, 2003
- The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosisEuropean Heart Journal, 2003